| Effect | Increase |
| Trial Design | Non-controlled trial |
| Trial Length | 1-6 months |
| Number of Subjects | 55 |
| Sex | Female |
| Age Range | 45-64 |
The usage of Melbrosia (royal jelly, pollen, perga-pollen) in post-menopausal women was able to decrease various symptoms of menopause as assessed by Kupperman score (survey) when supplemented at 2 caps daily for 2 weeks, then 1 cap daily for 10 week, for 12 weeks.
C-Reactive protein and VCAM-1 were not significantly affected.
